Freudenberg Medical Appoints New CEO
BEVERLY, MASS. – Freudenberg Medical has announced the appointment of Dr. Mark Ostwald as CEO. Dr. Ostwald previously served as Chief Technology Officer of Freudenberg Medical and is part of the Management Board. He joined Freudenberg Medical in 2009 and has held a number of leadership roles including President of Europe and head of Minimally Invasive Solutions, Vice President and General Manager of the Silicones Business Unit in California, and he helped establish the Kaiserslautern, Germany operation as Managing Director of Freudenberg Medical Europe.
Dr. Ostwald follows Dr. Max Kley who has been appointed CEO of a newly established Freudenberg business group for the fast-growing battery and fuel cell market. With more than thirty years of experience the Freudenberg Group is a leader in the transition to carbon-neutral energy systems.
“I am honored to lead the company at this exciting time of growth,” said Dr. Ostwald. “Freudenberg Medical is a great company with innovation at its core. Working with our talented team we will continue to push the envelope with new products and innovative technology to advance healthcare manufacturing and drive value for our customers.”
“Mark is the ideal candidate to lead Freudenberg Medical into the next phase of rapid growth and global expansion,” said Dr. Max Kley. “His strong focus on customer needs, his experience in the medical device industry and his international background ensure that Freudenberg Medical will continue to be a driving force for innovation and quality in the global medical device and pharmaceutical industries.”